Amgen, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Amgen, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4428
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Amgen, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Amgen, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Amgen, Inc., (Amgen or ‘the company’) is a biotechnology company involved in the discovery, development, manufacture, and marketing of human therapeutics. The company has expertise in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses. Its product portfolio includes Prolia(denosumab), XGEVA(denosumab), EVENITY (romosozumab), Repatha (evolocumab), Aimovig (erenumab), Aranesp (darbepoetin alfa), BLINCYTO (blinatumomab), KYPROLIS(carfilzomib), Vectibix (panitumumab), Sensipar/Mimpara (cinacalcet), and AMJEVITA (adalimumab-atto)/AMGEVITA (biosimilar adalimumab). The company has business presence across the US,Europe, LatinAmerica, the Middle East and Asia-Pacific. Amgen is headquartered in Thousand Oaks, California, the US.

Scope

- Detailed information on Amgen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments
- Intelligence on Amgen, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Amgen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Amgen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Amgen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Amgen, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Amgen, Inc.: Company Overview 9
Amgen, Inc.: Overview and Key Facts 9
Amgen, Inc.: Overview 9
Amgen, Inc.: Key Facts 9
Amgen, Inc.: Key Employees 11
Amgen, Inc.: Key Employee Biographies 13
Amgen, Inc.: Major Products and Services 20
Amgen, Inc.: Company History 21
Amgen, Inc.: Management Statement 29
Amgen, Inc.: Locations and Subsidiaries 34
Amgen, Inc.: Key Competitors 36
Amgen, Inc.: Company Analysis 37
Amgen, Inc.: Business Description 37
Amgen, Inc.: SWOT Analysis 40
Amgen, Inc.: SWOT Overview 40
Amgen, Inc.: Strengths 40
Amgen, Inc.: Weaknesses 41
Amgen, Inc.: Opportunities 41
Amgen, Inc.: Threats 42
Amgen, Inc.: Corporate Financial Deals Activity 44
Amgen, Inc.: Financial Deals Overview 44
Amgen, Inc.: Targets and Partners 46
Amgen, Inc.: Top Deals 2014 – 2018YTD* 48
Amgen, Inc.: Advisors 49
Amgen, Inc.: Top Legal Advisors 49
Amgen, Inc.: Top Financial Advisors 49
Amgen, Inc.: Mergers and Acquisitions 51
Amgen, Inc.: Corporate Venturing 52
Amgen, Inc.: Capital Raising 53
Amgen, Inc.: Partnership 54
Amgen, Inc.: Divestments 55
Amgen, Inc.: Recent Developments 56
Amgen, Inc.: News and Events Summary 56
Amgen, Inc.: Business Expansion 61
Amgen, Inc.: Contracts 62
Amgen, Inc.: Corporate Governance 63
Amgen, Inc.: Financial Performance 64
Amgen, Inc.: Strategy and Operations 64
Appendix 66
Contact Us 66
Methodology 66
About MarketLine 67

List of Tables
Table 1: Amgen, Inc.: Key Facts
Table 2: Amgen, Inc.: Key Employees
Table 3: Amgen, Inc.: Locations and Subsidiaries
Table 4: Amgen, Inc.: Key Competitors
Table 5: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Amgen, Inc.: M&A Activity by Geography (TTM*)
Table 7: Amgen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Amgen, Inc.: Targets and Partners
Table 10: Amgen, Inc.: Top Deals 2014 - 2018YTD*
Table 11: Amgen, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Amgen, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Amgen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Amgen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Amgen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Amgen, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Amgen, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Amgen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Amgen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Amgen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: Amgen, Inc.: News and Events Summary
Table 23: Amgen, Inc.: Business Expansion
Table 24: Amgen, Inc.: Contracts
Table 25: Amgen, Inc.: Corporate Governance
Table 26: Amgen, Inc.: Financial Performance
Table 27: Amgen, Inc.: Strategy and Operations

List of Figures
Figure 1: Amgen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Amgen, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Amgen, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Amgen, Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Amgen, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Amgen, Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Amgen, Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Amgen, Inc.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Amgen, Inc.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Amgen, Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Amgen, Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Amgen, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Amgen, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ben E. Keith Co:企業の戦略的SWOT分析
    Ben E. Keith Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Sirenas LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sirenas LLC (Sirenas), formerly Sirenas Marine Discovery LLC, is a biotechnology company that discovers therapeutics derived from nature's chemistry. The company’s proprietary data mining technologyATLANTIS uses data mining and machine learningapproach to uncover the therapeutic potential of …
  • British American Tobacco p.l.c.:戦略・SWOT・企業財務分析
    British American Tobacco p.l.c. - Strategy, SWOT and Corporate Finance Report Summary British American Tobacco p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Holder Construction Co:企業の戦略的SWOT分析
    Holder Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Medline Industries Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medline Industries Inc (Medline) is a manufacturer and distributor of healthcare supplies in the US. The company offers products under various categories, including Exam Gloves, Textiles, Durable Medical Equipment, Skin Care, OR Kits, Protective Apparel, Gauze, Packs and Gowns, Bathing Syste …
  • Vect-Horus SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Vect-Horus SAS (Vect-Horus) is a biotechnology company that designs and develops peptide-based vectors to facilitate the delivery of drugs or imaging agents into organs including the brain and tumors. The company combines molecules of interest to peptide-vectors that targets receptor mediate …
  • SpareBank 1 SMN:企業の戦略・SWOT・財務分析
    SpareBank 1 SMN - Strategy, SWOT and Corporate Finance Report Summary SpareBank 1 SMN - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Otto Bock HealthCare GmbH:企業の戦略的SWOT分析
    Otto Bock HealthCare GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Elite Surgical Supplies (Pty) Ltd:製品パイプライン分析
    Summary Elite Surgical Supplies (Pty) Ltd (Elite Surgical) is a medical device company that manufactures and distributes surgical instruments. The company provides spinal, arthoplasty and consumable surgical instruments. Its spinal products include stand alone equipment, cervical cage, boiling VBR, …
  • NV Bekaert SA:戦略・SWOT・企業財務分析
    NV Bekaert SA - Strategy, SWOT and Corporate Finance Report Summary NV Bekaert SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SDIX LLC:医療機器:M&Aディール及び事業提携情報
    Summary SDIX LLC (SDIX), a subsidiary of OriGene Technologies Inc, is an immuno-solutions company that develops antibody-based solutions. The company provides IVD solutions and premade antibiotics, among others. Its IVD solutions provide co-development of analyte-specific reagents, diagnostic menu e …
  • Louis Dreyfus Company B.V.:企業の戦略的SWOT分析
    Louis Dreyfus Company B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hino Motors, Ltd.:企業の戦略・SWOT・財務情報
    Hino Motors, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hino Motors, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Information Services International-Dentsu Ltd (4812):企業の財務・戦略的SWOT分析
    Information Services International-Dentsu Ltd (4812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Standard Chartered Plc:企業の戦略・SWOT・財務情報
    Standard Chartered Plc - Strategy, SWOT and Corporate Finance Report Summary Standard Chartered Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • BelAZ:企業の戦略・SWOT・財務情報
    BelAZ - Strategy, SWOT and Corporate Finance Report Summary BelAZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Oil-Dri Corporation of America (ODC):企業の財務・戦略的SWOT分析
    Summary Oil-Dri Corporation of America (Oil-Dri) is a manufacturer and supplier of sorbent products. The company offers granular clay absorbents, universal absorbent products, oil only absorbents, haz mat, socks and boom, spill kits, sweeping compounds, and secondary containment products. Its univer …
  • Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule h …
  • Eesti Energia AS-エネルギー分野:企業M&A・提携分析
    Summary Eesti Energia AS (Eesti Energia) is an international energy company that offers energy solutions ranging from electricity, heat and fuel production to sales, customer service and ancillary energy services among others. Eesti Energia sells electricity to the Baltic retail customers and the wh …
  • The Manufacturers Life Insurance Co:電力:M&Aディール及び事業提携情報
    Summary The Manufacturers Life Insurance Company (Manufacturers Life Insurance) is a financial service provider, based in Canada. The company provides financial protection, and wealth management products and services, and also asset management services to institutional customers. It offers individua …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆